Topic Hub
15 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 15 of 15 clinical reviews.
A clinician-reviewed guide for teens aged 12 to 17 taking Provigil (modafinil) as they transition to adult medical care, covering dose adjustments, monitoring requirements, prescriber handoff protocols, and what changes after age 18.
Read clinical reviewStep-by-step caregiver guidance for administering Provigil (modafinil) to adolescents ages 12 to 17, including dosing, timing, safety monitoring, and FDA-approved indications.
Read clinical reviewA clinical guide to modafinil use in geriatric patients aged 65 and older, covering dose adjustments, cognitive activity considerations, drug interactions, and safety monitoring for older adults.
Read clinical reviewComplete caregiver guide to administering Provigil (modafinil) in adults aged 65 and older, including dose adjustments, drug interactions, monitoring parameters, and safety considerations reviewed by the HealthRX medical team.
Read clinical reviewA physician-reviewed guide to off-label modafinil use in adolescents ages 12 to 17, covering the FDA approval status, clinical trial data, safety signals, and how prescribers approach dosing in this age group.
Read clinical reviewA clinician-reviewed guide to modafinil use in adolescents ages 12 to 17, covering academic performance, extracurricular activity, sleep timing, dosing, and safety considerations backed by primary evidence.
Read clinical reviewA clinically detailed guide to modafinil use in patients aged 65 and older, covering pharmacokinetics, cognitive effects, safety signals, dosing adjustments, and what current evidence actually shows.
Read clinical reviewA physician-reviewed guide to off-label modafinil use in geriatric patients covering evidence, starting doses, drug interactions, and safety considerations for adults 65 and older.
Read clinical reviewA clinical guide to modafinil use in patients aged 65 and older, covering dose adjustments, drug interactions, sleep-disorder management, and what to discuss when transitioning from adult to geriatric care.
Read clinical reviewA clinician-reviewed guide for caregivers administering modafinil (Provigil) to children under age 12, covering dosing, safety, scheduling, and FDA regulatory context.
Read clinical reviewA clinician-reviewed guide to managing modafinil therapy in pediatric patients under age 12 and planning the transition to adult care, including dosing, monitoring, and regulatory context.
Read clinical reviewA physician-reviewed guide to modafinil (Provigil) use in pediatric patients under age 12, covering developmental risks, neurocognitive effects, growth concerns, FDA status, and evidence from clinical trials.
Read clinical reviewA physician-reviewed guide to off-label modafinil use in pediatric patients under age 12, covering evidence, safety signals, FDA status, dosing considerations, and when prescribing may be appropriate.
Read clinical reviewA detailed clinical review of modafinil (Provigil) use in adolescents aged 12-17, covering neurodevelopmental risks, growth effects, psychiatric concerns, FDA status, and evidence-based decision frameworks for prescribers.
Read clinical reviewA clinician-reviewed guide to modafinil (Provigil) use in children under 12, covering school performance, physical activity, safety data, dosing context, and what parents and educators need to know.
Read clinical review